Suxamethonium Aguettant 10 mg/ml, solution injectable en seringue préremplie

7680699390014 CH-69939 Lösung

No image available

Article details

Package size
10
Selling units
10
Measure
Fertigspritze(n)
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
29/10/2025
Summary of Product Characteristics
Français
29/10/2025
Summary of Product Characteristics
Italien
29/10/2025

Detailed composition

Substance Quantity Type Category
suxamethonii chloridum anhydricum
10.0 MG Substance Wirkstoff (Principe actif)
suxamethonii chloridum dihydricum
- Substance WIZUS
natrii chloridum
- Substance HNIDK
acidum succinicum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
2.79 MG Substance HBESI

Authorization holder

Aguettant Suisse SA

1226 Thônex

Authorization information

Swissmedic authorization number
69939
Drug name
Suxamethonium Aguettant, solution injectable en seringue préremplie
Galenic form
INFFS
ATC Code
M03AB01
Authorization status
Z
Dispensing category
B
First authorization
01/07/2025
Authorization expiration date
30/06/2030
IT Number
01.13.0.
Domain
Human medicine

Package details

Description (FR)
SUXAMETHONIUM Aguettant 10 mg/ml sol inj 10 mg 10
Description (DE)
SUXAMETHONIUM Aguettant 10 mg/ml Inj Lös 10 mg 10
Market launch
08/05/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data